New Drug Formulation Could Improve HIV Treatment in Children
University of Colorado Anschutz Medical Campus
Research confirms the safety and effectiveness of the first child-friendly single fixed-dose combination HIV treatment
Treatments
FDA Approves First Topical Gene Therapy for Dystrophic Epidermolysis Bullosa Wounds
U.S. Food and Drug Administration
Around 65 percent of the wounds treated with Vyjuvek showed complete wound closure in DEB patients
WHO Updates COVID-19 Guidelines
World Health Organization
Updates to the guidelines relate to masks, treatments, and isolation periods
FDA Approves New HIV Drug for Adults with Limited Treatment Options
U.S. Food and Drug Administration
The new medication is for those whose HIV infections cannot be successfully treated with other treatments
Monoclonal Antibody Treatment No Longer an Option for COVID-19
Swathi Kodaikal, MSc
All six of the available mAbs for SARS-CoV-2 have been rendered ineffective and deauthorized by the FDA
Harnessing Oncolytic Viruses to Defeat Cancer
Boris Minev, MD
Newer approaches to oncolytic virus-based therapies show promise
Widespread Bias, Discrimination Directed toward People with Disabilities
Northwestern University
Physicians in focus groups reported making statements such as ‘I am not the doctor for you'
Ethics Not Only Allow but Demand Placebo in Some HIV Cure Trials
Rutgers University
Ethicists argue for the ethics of stopping antiretroviral treatment for patients who receive a placebo
Reinfection Rates Low after Successful HCV Treatment in People Who Inject Drugs
American College of Physicians
Cohort study indicates risk of reinfection highest in the first 24 weeks after treatment
COVID-19 Therapeutics Research Reaches New Highs
María Carla Rosales Gerpe, MSc, PhD
Monoclonal antibodies remain top option for COVID-19 treatment, but studies reveal a potential alternative